Binding of new cirazoline derivative to imidazoline receptors from human brain.
Imidazoline compounds are known to interact with alpha 2-adrenoceptors as well as with specific non-adrenergic binding sites. Such binding sites are present in the brain and in peripheral tissues. Hypotensive effects of imidazolines were shown to be related to specific interaction with imidazoline binding sites within the brainstem. Heterogeneity of these sites based on differences in selectivities was reported. In order to facilitate the characterization of human brain imidazoline receptors, we synthetized new ligands by substitutions on the cirazoline phenyl ring. Affinities of these cirazoline derivatives were determined in two imidazoline binding site models, namely the human brain and the rabbit kidney. Interaction of these compounds with imidazoline binding sites from the human brain appeared more sensitive to structural variations of the imidazoline than those with rabbit kidney sites. Moreover, no correlation was found between affinities for imidazoline binding sites and those for alpha 2-adrenoceptors of the rat brain. Arylazide derivative of 2-(5-amino-2-methyl-phenoxymethyl)-imidazoline exhibited a higher affinity for human brain imidazoline binding sites than for human brain alpha 2-adrenoceptors. Photoincorporation of this azido-compound in human brain imidazoline binding sites was achieved and blockade of [3H]idazoxan imidazoline specific binding observed. These new tools may allow fine characterization of the different subtypes of imidazoline binding proteins.
Dontenwill
M
M
Laboratoire de pharmacologie cardiovasculaire et rénale, CNRS ERS109, Université Louis Pasteur, Faculté de médecine, Strasbourg, France.
Ehrhardt
J D
JD
Senecheau
P
P
Molines
A
A
Greney
H
H
Bousquet
P
P
D000316:Adrenergic alpha-Agonists / Q000378:metabolism*; D000818:Animals; D001665:Binding Sites; D001921:Brain / Q000378:metabolism* / Q000648:ultrastructure; D003000:Clonidine / Q000378:metabolism; D006801:Humans; D019329:Idazoxan / Q000378:metabolism; D007093:Imidazoles / Q000737:chemistry / Q000378:metabolism*; D054755:Imidazoline Receptors; D007668:Kidney / Q000378:metabolism; D008928:Mitochondria / Q000378:metabolism; D010777:Photochemistry; D011817:Rabbits; D051381:Rats; D011955:Receptors, Drug / Q000378:metabolism*; D014316:Tritium; D014466:Ultraviolet Rays; D015016:Yohimbine / Q000378:metabolism
D000316:Adrenergic alpha-Agonists; D007093:Imidazoles; D054755:Imidazoline Receptors; D011955:Receptors, Drug; D014316:Tritium; D015016:Yohimbine; D003000:Clonidine; C014282:cirazoline; D019329:Idazoxan